↓ Skip to main content

Dove Medical Press

Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder

Overview of attention for article published in Therapeutics and Clinical Risk Management, August 2008
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
34 Mendeley
Title
Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder
Published in
Therapeutics and Clinical Risk Management, August 2008
DOI 10.2147/tcrm.s3153
Pubmed ID
Authors

Walter Deberdt, Ilya Lipkovich, Alexandra N Heinloth, Lin Liu, Sara Kollack-Walker, Sara E Edwards, Vicki Poole Hoffmann, Thomas A Hardy

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 26%
Student > Bachelor 4 12%
Student > Master 4 12%
Student > Postgraduate 3 9%
Other 2 6%
Other 4 12%
Unknown 8 24%
Readers by discipline Count As %
Medicine and Dentistry 10 29%
Neuroscience 3 9%
Nursing and Health Professions 2 6%
Biochemistry, Genetics and Molecular Biology 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Other 6 18%
Unknown 9 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2017.
All research outputs
#8,537,346
of 25,377,790 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#34,789
of 97,953 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 7 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,953 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.